Philipp Schütt

Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections

Philipp Schütt, Dieter Brandhorst, Werner Stellberg et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2006 · 125 citations

Medicine, Hematology, Immunology +15

Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients

Vera Rebmann, Philipp Schütt, Dieter Brandhorst et al. · Clinical Immunology · 2007 · 89 citations

Medicine, Clinical Sciences, Oncology +11

Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP)

Martin Faehling, Christian Schumann, Petros Christopoulos et al. · Lung Cancer · 2020 · 75 citations

Medicine, Oncology, Radiation Oncology +15

Prognostic relevance of soluble human leukocyte antigen–G and total human leukocyte antigen class I molecules in lung cancer patients

Philipp Schütt, Birgit Schütt, Magdalena Switala et al. · Human Immunology · 2010 · 66 citations

Life Sciences, Immunology, Oncology +13

A Novel Nonobese Diabetic/Severe Combined Immunodeficient Xenograft Model for Chronic Lymphocytic Leukemia Reflects Important Clinical Characteristics of the Disease

Jan Dürig, Peter R. Ebeling, Florian Grabellus et al. · Cancer Research · 2007 · 63 citations · Full text

Medicine, Hematology, Oncology +15